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AbstrAct
Objective Cultural backgrounds and values 
have a decisive impact on the phenomenon of 
the wish to die (WTD), and examination of this 
in Mediterranean countries is in its early stages. 
The objectives of this study were to establish 
the prevalence of WTD and to characterise this 
phenomenon in our cultural context.
Methods A cross- sectional study with 
consecutive advanced inpatients was conducted. 
Data about WTD (Assessing Frequency & 
Extent of Desire to Die (AFFED) interview) and 
anxiety and depression (Edmonton Symptom 
AssessmentSystem- revised (ESAS- r)) were 
collected through two face- to- face clinical 
encounters. Data were analysed with descriptive 
statistics, χ2 and analysis of variance.
results 201 patients participated and 165 
(82%) completed both interviews. Prevalence 
of WTD was 18% (36/201) in the first interview 
and 16% (26/165) in the second interview 
(p=0.25). After the first interview, no changes 
in depression (p=0.60) or anxiety (p=0.90) 
were detected. The AFFED shows different 
experiences within WTD: 11% of patients 
reported a sporadic experience, while 7% 
described a persistent experience. Thinking 
about hastening death (HD) appeared in 8 
(22%) out of 36 patients with WTD: 5 (14%) 
out of 36 patients considered this hypothetically 
but would never take action, while 3 (8%) out 
of 36 patients had a more structured idea about 
HD. In this study, no relation was detected 
between HD and frequency of the appearance 
of WTD (p=0.12).
conclusions One in five patients had WTD. 
Our findings suggest the existence of different 
experiences within the same phenomenon, 
defined according to frequency of appearance 
and intention to hasten death. A linguistically 
grounded model is proposed, differentiating the 
experiences of the ‘wish’ or ‘desire’ to die, with 
or without HD ideation.
IntrOductIOn
There is now growing interest in studying 
the phenomenon of the wish to die (WTD) 
in the clinical and research setting.1–4 
Studies discuss the multifactorial nature 
of this phenomenon, taking in the influ-
ence of physical, psychosocial, spiritual- 
existential and social factors1 or those 
related to the patient’s personal character-
istics. The experience of WTD has been 
described as a dynamic phenomenon, 
which fluctuates over time,5–9 and which 
may form part of the process of adapting to 
illness.10 There may be coexisting, contra-
dictory sentiments of WTD and wishing 
to live at the same time.9 These charac-
teristics make WTD a complex phenom-
enon, in which it is necessary to examine 
in depth each person’s experience. The 
available data on its prevalence are vari-
able, ranging between 11% and 55% in 
different studies. As to the variability of 
data, the influence of the complexity of 
the experience and the diverse cultural 
contexts in which each study is under-
taken are undeniable.3 11–20
Over the last 5 years in Spain, the 
situation of the wish to hasten death 
(WTHD) and its associated factors have 
been investigated. The first study was 
published in 2014, with the objectives of 
examining the validity and reliability of 
the Spanish version of Schedule of Atti-
tudes toward Hastened Death (SAHD) 
and exploring factors associated with the 
WTHD.21 The results showed that SAHD 
has good psychometric properties, but 
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professionals reported that in our cultural context, the 
questionnaire proved difficult to use, due to language 
that is perceived by Spanish patients as strong or overly 
direct. In this study, the WTHD was associated with 
emotional distress and patients’ functional status.21 
Another study compared two different approaches to 
assessing WTHD: the short form of the Schedule of 
Attitudes toward Hastened Death (SAHD-5) and the 
Desire for Death Rating Scale (DDRS).22 The results 
showed that these two methods may provide comple-
mentary information: the SAHD-5 as a screening tool 
and the DDRS as a clinical interview to explore the 
phenomenon in greater detail.
Porta- Sales et al designed a four- item interview 
guide (Assessing Frequency & Extent of Desire to Die 
(AFFED)) adapted to our cultural setting.23 It was 
based on the experience of conversations on the WTD 
with patients, which allowed us to note the frequency, 
characteristics and reasons for considering this. A 
study was undertaken at an oncology hospital in Cata-
lonia to see whether an AFFED- guided clinical inter-
view would be upsetting for the patient. Most patients 
(95%) accepted the interview using AFFED questions, 
and reported no negative feelings. The AFFED guide 
was also used in another study, showing that WTHD 
was significantly associated with perceptions of dignity 
and control.24
In our setting, the exploration of reasons for the 
WTD is thus recent and limited to the studies cited 
from Catalonia. The present study was designed to 
determine the prevalence of the WTD in a Spanish 
population with patients from different regions, to 
go deeper into the characteristics of this phenomenon 
(frequency and extension) and the implications of 
examining it by means of a clinical interview (stability 
and repercussion on their emotional status).
MethOds
A transversal study was designed to explore the expe-
rience of the WTD among patients receiving special-
ised palliative care (PC) at two hospitals in Pamplona. 
Participants were from all over the country: 36% had 
been born in the region of Navarra and 64% were 
from different regions.
Inclusion criteria were (1) advanced stage illness; (2) 
expectancy of death in the short term, estimated via 
‘surprise question’ with a time frame of 1 year by the 
patient’s attending physician; (3) awareness of their 
diagnosis; (4) intact cognitive capacity; and (5) ability 
to understand Spanish well. Exclusion criteria were 
(1) final days’ situations and (2) clinical context which 
advised against interview, following the attending 
physician’s criteria, with notes taken as to reasons for 
exclusion.
data collection
Data were collected between January and November 
2018. Two interviews were planned for each patient, 
conducted by an experienced palliative care researcher 
with a nursing background, clinical experience at the 
bedside of patients with advanced conditions and 
trained in difficult conversations with patients. On 
the first day, sociodemographic and clinical data were 
collected and a semistructured interview was carried 
out on the WTD, using the AFFED questionnaire. 
Symptom intensity was evaluated using the Edmonton 
Symptom Assessment System- revised (ESAS- r) ques-
tionnaire. At 48–72 hours, the interview was repeated 
with the AFFED questionnaire and the ESAS- r was 
once again applied. Patients received standard care 
during the study. When the experience of WTD was 
detected and after patient consent during the interview, 
the care team was informed so they could address this 
in the course of patient care.
Instruments
The AFFED interview guide was created to examine 
the phenomenon of WTD in our cultural setting. It 
is designed to hold a short, simple, respectful conver-
sation which can be easily applied in clinical practice. 
Using four successive questions, existence, frequency, 
extension and potential causes are examined. The 
interview begins with an indirect question to detect 
the existence of the phenomenon. After the sense of 
the initial response has been verified, a binary answer 
is recorded (yes/no); when the response is clearly affir-
mative, the researcher continues by examining the 
frequency of occurrence (almost never; sometimes; 
not every day, but almost every day; everyday). The 
extension of the phenomenon is established, keeping 
in mind which people are affected and above all, if the 
wish is accompanied, or not, by the idea of hastening 
death (HD) (eg, it has only been considered by the 
patient themselves; it has also been the subject of 
discussion with somebody else; they have thought of 
ending their own lives but they would never do it; they 
have thought about ending their lives in some way). In 
this study, HD includes different thoughts or actions 
about ending life, encompassing suicidal ideation. The 
final question examines the potential causes of this 
situation in the patient’s eyes (pain or other symptoms; 
psychological aspects; social aspects; beliefs or values; 
other reasons, which are recorded).
The ESAS- r is a symptom evaluation survey, with a 
verbal numerical scale, on the 10 most common symp-
toms in advanced stage illness, including anxiety and 
depression.25 26
statistical analysis
A descriptive statistical analysis was carried out on 
the results obtained with the AFFED guide. The rela-
tionship between the dimensions of the frequency of 
appearance and extension were established using χ2. 
Calculations were made in the changes shown in the 
variables of presence of WTD, anxiety and depression 
after the initial interview, using analysis of variance 
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Table 1 Sociodemographic and clinical characteristics
Total patients (N=201) N (%)
Age (n, range) 67 (23–94)
Sex: Female 92 (46)
Occupation
  Retired 132 (66)
  Employed 32 (16)
  Homemaker 4 (2)
  Other 33 (16)
Educational level
  Without studies 3 (1)
  Primary school 74 (37)
  High school 35 (18)
  Vocational training 31 (15)
  University 58 (29)
Marital status
  Single 27 (13)
  Married or with a partner 120 (60)
  Widower 27 (13)
  Separated, divorced 17 (9)
  Other 10 (5)
Religious practice
  Practising and believer 94 (47)
  Non- practising and believer 78 (39)
  Not believer 29 (14)
History of depression 23 (11)
History of anxiety disorder 15 (7)
Primary tumour
  Gastrointestinal system 63 (32)
  Respiratory system 42 (21)
  Reproductive system 45 (22)
  Excretory system 23 (11)
  Others 25 (14)
Amyotrophic lateral sclerosis 3 (1)
Chronic disease 1 (1)
Information
  Suspect or known diagnostic but does not speak 5 (3)
  Diagnostic but not prognostic 97 (48)
  Diagnostic and prognostic 99 (49)
Treatment received (last 3 months)
  None 48 (24)
  QT 89 (44)
  RT 20 (10)
  QT+RT 12 (6)
  Other 32 (16)
Functional status (Karnofsky)
  <50 23 (11)
  50–70 151 (76)
  >70 27 (13)
QT, chemotherapy; RT, radiotherapy.
(ANOVA). Analysis was carried out using STATA V.15 
(StataCorp LP, College Station, Texas, USA). Results 
with p<0.05 were deemed significant.
results
A total of 475 patients were admitted during the 
study period to the hospitals but just 234 (49%) met 
the inclusion criteria. Of those who met the inclusion 
criteria, 201 (86%) took part in the study: 31 patients 
refused to talk about profound aspects and 2 patients’ 
relatives considered it better for the patient not to 
participate. Of the 201 inpatients who participated 
in the first interview, 165 (82%) did the second inter-
view, with an average interval of 3.5 days. Ten patients 
did not repeat the interview because they did not wish 
to discuss the subject again, and 26 for reasons uncon-
nected to the matter being studied. Interviews lasted 
between 20 and 60 min.
The patients’ sociodemographic characteristics 
are shown in table 1. Average age was 67 years and 
46% were female. The majority claimed to hold reli-
gious beliefs (86%) as usual considering the country’s 
history and tradition, almost all of them were aware of 
the diagnosis (97%) and the Karnofsky score for 76% 
of patients was between 50 and 70.
In the population studied, 36 (18%) out of 201 
patients claimed at interview to have experienced, 
in some way, the WTD (see table 2): 22 (11%) occa-
sionally, 3 (2%) nearly every day, 11 (5%) every day. 
The rest said they had never or almost never felt that 
way. Among those patients who had experienced the 
WTD, 8 (22%) out of 36 had considered the idea of 
HD; 5 described a more hypothetical idea of HD, 
because they said they would not go through with it; 
3 had more consistent ideas of HD, 1 of whom spon-
taneously manifested suicidal ideation. No premature 
death was recorded among the patients interviewed.
There was no association between the experience 
of HD in these eight patients and the frequency of 
the appearance of the WTD (χ2, p=0.151) (table 3). 
Neither was any association found by dichoto-
mising the item concerning frequency of the WTD, 
as ‘sporadic’ (sometimes) or ‘persistent’ (everyday or 
almost every day) against the existence, or not, of the 
HD (p=0.12) (table 4).
We examined whether there were changes in the 
existence of the WTD phenomenon between the two 
interviews. In the first interview, the WTD was present 
in 18%, and in the second in 16%, and no significant 
differences were detected (ANOVA, p=0.25). During 
these days, patients received standard palliative care.
No significant changes were detected either between 
the two interviews, or on the anxiety (p=0.90) or 
depression (p=0.60) levels measured with the ESAS- r.
The reasons for WTD referred to by patients were 
pain or other symptoms (33%), psychological aspects 
(33%), the feeling of being a burden on the family 
(24%), existential aspects (8%) and a poor perception 
of their own dignity (2%). Twenty- six per cent referred 
to more than one reason for WTD.
dIscussIOn
In this study, nearly one in every five patients inter-
viewed admitted to having experienced, to some 
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Table 2 AFFED interview guide results











Some people in your situation may involuntarily start to 
think that living like this is not worth it any more. Lately 
(in the last week or two) have you thought that living like 
this is not worth it? (N=201)
No, never 158 (78)
Seldom/almost ever 7 (3)
Occasionally/sometimes 22 (11)
Not every day but almost every day 3 (2)











When you have had this thought or feeling, have you only 
thought about it (that you wanted to die) or have you 
gone further? (N=36)
Only thought about it 10 (28)
Have talked about/mentioned it to someone 18 (50)
Have thought about ending life, but never 
would do it
5 (14)
Yes, there is a plan- they may or may not be 









What makes you think or feel like that? (N=36)
Pain or other symptoms 17 (48)
Psychological aspects 18 (50)
Social or relational aspects 11 (31)
Beliefs/values 2 (6)
Other motives 3 (8)
Translation: Q1: Algunas personas en su situación, aunque a veces no 
lo desean, llegan a pensar que vivir así no vale la pena. En las últimas 
semanas, ¿ha pensado -alguna vez -algo así?
Q2: Cuando ha tenido este pensamiento / sentimiento, ¿solo lo ha 
pensado o ha ido más lejos (haciendo referencia a si ha considerado 
adelantar la muerte)?
Q3: ¿Qué le hace pensar o sentirse así?
AFFED, Assessing Frequency & Extent of Desire to Die.







mentioned it to 
someone
Have thought about 
ending life, but never 
would do it
Yes, there is a plan—
they may or may not 
be able to explain it Total
Occasionally/sometimes 7 12 3 0 22
Not every day, almost every day 0 2 1 0 3
Every day 2 5 1 3 11
Total 9 19 5 3 36
p=0.151.
AFFED, Assessing Frequency & Extent of Desire to Die.
Table 4 Relationship between the frequency of the WTD (Q1) 










Sporadic* 19 3 22
Persistent† 9 5 14
Total 28 8 36
p=0.120.
*Included patients that answer Q1 ‘occasionally/sometimes’.
†Included patients that answer Q1 ‘every day’ or ‘almost every day’.
‡Included patients that answer Q2 ‘only thought about it’ or ‘have 
talked about/mentioned it to someone’.
§Included patients that answer Q2 ‘Have thought about ending life, but 
never would do it’ or ‘Yes, there is a plan— they may or may not be 
able to explain it’.
AFFED, Assessing Frequency & Extent of Desire to Die; WTD, wish to die.
extent, a type of WTD. This is the second study on 
the subject undertaken in our country with advanced 
patients, using a similar method based on personal 
patient interviews. The similarities between the two 
studies are important regarding the suitability of the 
method used to research the WTD. Our study thus 
provides independent confirmation that the AFFED 
as proposed by Porta et al23 is a feasible, innocuous 
method for use with advanced patients. Nearly all 
the patients were receptive to the interview with the 
questions as planned (even when repeated a second 
time). Moreover, earlier results were confirmed in 
that the research method does not prove upsetting, 
and we might add that there are no significant changes 
observed in levels of anxiety and depression measured 
on ESAS- r over the following days. In summary, the 
AFFED interview guide is confirmed as a suitable 
guide to examine the phenomenon of the WTD in our 
setting.
In the other study cited,23 the prevalence of the 
WTD was seven percentage points higher. This small 
difference may be explained by the difference in the 
way of categorising the existence of the experience of 
the WTD in the two studies, as well as some differ-
ences in the characteristics of the patients taking part. 
In our study, the response by seven patients of having 
experienced the WTD, just sporadically, or on isolated 
occasions, equated to the response of not having felt 
the WTD. There are two reasons for this: on the one 
hand, the answer ‘almost never’ is much closer to ‘no’ 
than to repeated existence; on the other hand, the 
context of the interviews makes us suspect that some 
advanced patients might answer ‘almost never’, as a 
way of not negating the fact that sometimes the idea of 
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Figure 1 Different experiences of the ‘wish to die’ considering 
the frequency of occurrence of the phenomenon and the 
existence or not of hasten death ideation, in a sample of 
201 Spanish patients (*). *We consider that a patient has 
experienced the ‘wish to die’ if he/she mentions having 
experienced it at some time. When this experience occurs every 
day or almost every day, we consider it a ‘desire to die’. The 
idea of ‘hastening death’ might be present occasionally in both 
experiences, and may be either hypothetical or consistent.
dying is indeed present. If we applied this criterion to 
both studies, the data on prevalence would be identical 
for the study on patients from different regions and 
that with patients solely from Catalonia.
Among the patients who experienced a signifi-
cant WTD, the AFFED guide, which examines the 
frequency of the presence of the WTD, allowed us to 
determine that half of the patients had sporadic experi-
ences and the other half, a more persistent experience. 
Studies outside the Spanish context have estimated 
similar percentages considering the patients’ different 
experiences: between 11% and 45% of patients report 
the WTD in a transitory or occasional way3 11–20 and 
in 3%–20% of the cases, these feelings or thoughts are 
more persistent.3 11–13 15–19 27
In our study, data on prevalence did not see signif-
icant changes when the questions were repeated by 
means of the AFFED survey. Other studies suggest a 
diminished presence of the WTD merely as a result of 
the questioning process.28 29
Among patients who experienced the WTD, only 
a fifth claimed to have considered the idea of HD, 
independently of whether the WTD was more or less 
frequent. In the Catalonian study,23 only 1 out of 10 
patients claimed to have thought of HD and this idea 
was related to experiencing the WTD with greater 
frequency. The spontaneous expression of suicidal 
ideation in one of the patients interviewed shows the 
need for further studies exploring this issue, since it is 
possible that in this study someone else had this, but it 
was not explored.
Analysing AFFED results also proved very useful for 
an in- depth study of different experiences. The results 
reveal the existence of one group of patients with 
sporadic experiences, another with more persistent 
wishes and a few from both groups in whom the idea 
of HD was also present. Other studies suggest the exis-
tence of diverse experiences but do not distinguish the 
frequency of appearance, or the presence of ideas of 
cutting one’s life short.1 30
Our study shows that patients have different expe-
riences within the broader experience of WTD. This 
result underlies the importance of understanding these 
experiences from the forefront of the patients’ reality 
and taking the various nuances into consideration. 
When describing these experiences, linguistics also 
plays an important role. A consensus definition of the 
global phenomenon of WTD was recently accepted in 
which one of the authors of this paper participated.31 
This consensus was based on the health professionals’ 
perspective, and the decision was made to refer to the 
WTD as a ‘Wish to Hasten Death’. The analysis of our 
results leads us to prefer using the expression ‘Wish to 
Hasten Death’ only for situations in which this idea 
is truly identified in the patient’s experience. Thus, 
the need for a more fine- tuned definition of patients’ 
experiences should be emphasised.
With the aim of adjusting the terms used in the 
different experiences, results were discussed with two 
language experts from the University of Navarra, one 
English (RB) and one Spanish (IO). A linguistic anal-
ysis was conducted which discussed specific terms in 
order to understand and characterise the phenomenon 
and provide the terminological clarity which literature 
demands.5 21 32 33 The way of examining the WTD 
proposed in the AFFED distinguishes between two 
different domains (frequency and extension), while 
the responses to the AFFED obtained in this study 
present three different experiences: one of a sporadic 
nature (sometimes), another persistent experience 
(always or almost always) and a third, with a different 
idea, referring to HD. As can be seen below, the lexical 
analysis allows us to identify each of these situations 
with precise terms: ‘wish to die’, ‘desire to die’ and 
‘hastening death’ (see figure 1).
Within the context of illness and aspiring to good 
health, the term ‘wish’ would be applied to a passing 
feeling, overridden as a hypothetical wish, or some-
thing out of reach or impossible, without any neces-
sary proactive attitude to pursuing what one wants. 
In clinical practice, transitory situations are observed 
in diverse circumstances (pain, emotions, loneli-
ness and so on) which lead to a reactive experience 
of WTD. This experience nearly always ceases when 
the cause disappears. The term ‘WTD’, in its strictest 
sense, would refer to sporadic or reactive experiences 




 August 5, 2020 by guest. Protected by copyright.
http://spcare.bmj.com/
BM
J Support Palliat Care: first published as 10.1136/bmjspcare-2020-002234 on 24 June 2020. Downloaded from 
 6 Belar A, et al. BMJ Supportive & Palliative Care 2020;0:1–7. doi:10.1136/bmjspcare-2020-002234
Original research
On other occasions, patients present an ongoing, 
persistent experience. In this case it is more appropriate 
to use the term ‘desire’ and not ‘wish’. Semantically, a 
desire is associated with a more intense, proactive atti-
tude towards obtaining what one wants or what one 
intensely anticipates or which is so highly wished for. 
In clinical practice, we observe patients in whom the 
experience of desire to die becomes somewhat more 
intense and ingrained in the person, transforming 
them into a voluntary, conscious agent of achieving 
this desire. The desire to die includes these persistent 
experiences.
In both situations (WTD and desire to die), the inten-
tion of HD may be present, or not, as a possible course 
of action, or even as a solely hypothetical situation. 
Only in these special cases, in contrast to those which 
exclude the idea of bringing the end nearer, should the 
expression ‘hasten death’ be added.
For the linguists consulted, for international 
consensus31 and for other authors,7 ‘to wish’ would be 
the appropriate verb to refer to the overall phenom-
enon. ‘Wish to die’ is a rather less acute expression and 
is more general than ‘desire to die’, the more semanti-
cally specific, concrete term.7
Therefore, within a common phenomenon, where 
the overall idea might be referred to as ‘wish to 
die’, there are three different experiences, which are 
referred to as ‘wish to die’, ‘desire to die’ and the wish 
or desire ‘to hasten death’, respectively. This concep-
tual proposal is what would be already insinuated 
in the distinction made by Chochinov et al,11 when 
differentiating patients with a sporadic ‘wish to die’, 
as opposed to others who present a ‘desire to die’. 
Although the conceptual proposal emerges from a 
study carried out in Spain, it may be useful in other 
cultures and it is up to future studies and researchers 
to determine its validity. Defining each experience 
with its corresponding term in other publications 
might help us achieve a deeper understanding of the 
complexity involved in experiencing the ‘wish to die’.
study limitations
The exploration of the WTD experience shows that 
it is innocuous within a range of 2–16 days, but we 
consider it would be beneficial to study whether its 
apparent harmlessness remains stable over a longer 
period of time. On the other hand, the discussion 
between clinical experts and linguists concerning 
the experience of WTD was conducted within the 
Spanish sociocultural context; it would be interesting 
to explore this subject in other sociocultural contexts.
clinical implications
Data show that the experience of the WTD is common 
in patients with advanced illness, and talking about it 
in a sensitive way proves harmless. These results may 
encourage professionals to explore systematically the 
experience of WTD without fear that this could be 
harmful for the patient. Concerning family and patients, 
this commonality may contribute to a certain normal-
isation of the experience, enabling more sincere and 
open communication about this experience between 
them. Moreover, the different experiences within the 
same phenomenon uncovered in this study provide 
deeper knowledge of the overall phenomenon. More 
profound insights into different experiences of this 
kind may help care professionals to achieve a greater 
understanding of the patients’ experience and thus 
provide better follow- up. This also may improve the 
comprehensive support for the patient’s relatives, who 
may suffer as a consequence of being exposed to the 
patients’ WTD. A terminological distinction between 
the different experiences involved may also contribute 
to more detailed research about this phenomenon, and 
further studies should be conducted to explore rela-
tionships between different experiences and associated 
factors (ie, disease).
Twitter Maria Arantzamendi @marantzamendi
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